Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
These affiliate relationships do not influence editorial content or product recommendations
Retatrutide pushes the frontier even further as a triple agonist that targets GLP-1, GIP, and glucagon receptors
The data in c e are the results of triplicate analyses
Tirzepatide is a once-weekly injectable medication that simultaneously activates two hormone receptors: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)
US$ 20.96
US$ 27.90
US$ 27.62
US$ 23.34
US$ 26.76
